Private Placement

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

A new advisory firm is tackling the opaque world of aesthetic device sales, promising to save providers up to $80,000 on high-ticket equipment.

Scholar Hotels is launching a $5,000 minimum investment platform for its State College properties, tapping into alumni loyalty and a new era of retail investing.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

With strategic investments and a new Cannes workshop, Yoshihiro Shimamura is building an integrated media empire to export Japanese culture worldwide.

With financials improving but competition rising, medical device maker Pulmonx faces a critical audience at the BofA healthcare conference in May.

The new AI platform iQ aims to translate complex supply chain threats into quantifiable financial exposure, giving CFOs a new tool for strategic decisions.

A new ultra-short-acting drug for cardiac emergencies is now in US hospitals, offering doctors faster control and broader use across all age groups.

A new FDA-Paradigm Health partnership uses AI to review clinical trial data in real time, aiming to cut drug development costs and approval delays.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

An $850M deal for an Arizona cobalt plant marks a pivotal US-Japan move to secure supply chains for defense, EVs, and advanced tech from rivals.

A new report shows 50% of founders fear AI disruption, while burnout and the timeless challenge of product-market fit continue to plague the startup world.

A new survey reveals Canadian millennials are disciplined savers for their kids' education, but a staggering 'confidence gap' shows the toll of today's economy.

The beverage startup partners with Hershey, betting on the power of nostalgia and the booming health-conscious market with its new candy-flavored teas.

As it preps a first-in-human study for a deadly genetic heart disease, Nuevocor brings on gene therapy veteran Dr. Monica Shah to lead the charge.

At 17, DeMarco built a million-dollar empire from his bedroom, defying legal hurdles and family conflict without spending a single dollar on advertising.

Set to unveil its "best of both" PRINT™ platform, Addition Therapeutics aims to cure diseases from Fabry to HIV with a single, durable genetic medicine.

Proptech giant SmartRent is moving beyond large complexes, launching a new program to bring smart home technology to millions of smaller rental properties.

As data centers and industry strain the grid, Red Post Energy hires a new CIO to lead a multi-billion dollar expansion into dispatchable power projects.